Amgen Forecasts FY23 Revenues Of $28B-$28.4B Versus Prior Guidance Of $26.6B-$27.4B And Consensus Of $27.54B
Portfolio Pulse from Benzinga Newsdesk
Amgen has updated its FY23 revenue forecast to $28B-$28.4B, up from the previous guidance of $26.6B-$27.4B and surpassing the consensus estimate of $27.54B.
October 31, 2023 | 11:16 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amgen's updated FY23 revenue forecast exceeds previous guidance and consensus estimates, indicating strong future performance.
Amgen's updated revenue forecast for FY23 is higher than both its previous guidance and the consensus estimate. This suggests that the company expects stronger performance in the future, which could positively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100